![Sergio Cifuentes: ctDNA for predicting response and prognosis in HER2-BC in NAC](https://oncodaily.com/pub/uploads/2024/05/Sergio-Cifuentes.jpg)
May 6, 2024, 20:08
Sergio Cifuentes: ctDNA for predicting response and prognosis in HER2-BC in NAC
Sergio Cifuentes, Cancer Research Project Manager at
“ctDNA for predicting response and prognosis in HER2-BC in NAC.
HR+: 145 and TNBC 138
TNBC: ctDNA have correlation with RCB and DFRS
HR+: ctDNA have correlation with DRFS.”
Proceed to the article.
Source: Sergio Cifuentes/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023